acrv: the income statement

MyFinsight

Acrivon Therapeutics, Inc. (ACRV)

For the quarter ending 2025-06-30, ACRV made $1,730K in revenue. -$21,183K in net income. Net profit margin of -1224.45%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Unrealized (loss) gain on available-for-sale investments, net of tax	-177
Research and development	16,182
General and administrative	6,467
Total operating expenses	22,649
Loss from operations	-22,649
Other expense, net	-87
Interest income	1,730
Total other income, net	1,643
Net loss	-21,006
Comprehensive loss	-21,183

Net loss per sharebasic	-0.55
Net loss per sharediluted	-0.55
Weighted-average common stock outstandingbasic	38,461,619
Weighted-average common stock outstandingdiluted	38,461,619

Unit: Thousand (K) dollars (except for numbers of shares and EPS)